Clinical recommendations for posttransplant assessment of anti–HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation …
C Lefaucheur, K Louis, AB Morris, JL Taupin… - American Journal of …, 2023 - Elsevier
Abstract Although anti–HLA (Human Leukocyte Antigen) donor-specific antibodies (DSAs)
are commonly measured in clinical practice and their relationship with transplant outcome is …
are commonly measured in clinical practice and their relationship with transplant outcome is …
[HTML][HTML] Significance of HLA-DQ in kidney transplantation: time to reevaluate human leukocyte antigen–matching priorities to improve transplant outcomes? An expert …
The weight of human leukocyte antigen (HLA) matching in kidney allocation algorithms,
especially in the United States, has been devalued in a stepwise manner, supported by the …
especially in the United States, has been devalued in a stepwise manner, supported by the …
[HTML][HTML] The Banff 2022 Kidney Meeting Report: reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics
M Naesens, C Roufosse, M Haas, C Lefaucheur… - American Journal of …, 2024 - Elsevier
Abstract The XVI-th Banff Meeting for Allograft Pathology was held at Banff, Alberta, Canada,
from 19th to 23rd September 2022, as a joint meeting with the Canadian Society of …
from 19th to 23rd September 2022, as a joint meeting with the Canadian Society of …
[HTML][HTML] Sensitization in transplantation: assessment of risk 2022 working group meeting report
Abstract The Sensitization in Transplantation: Assessment of Risk workgroup is a
collaborative effort of the American Society of Transplantation and the American Society of …
collaborative effort of the American Society of Transplantation and the American Society of …
Randomized trial to assess the clinical utility of renal allograft monitoring by urine CXCL10 chemokine
P Hirt-Minkowski, J Handschin, S Stampf… - Journal of the …, 2023 - journals.lww.com
Background Urine CXCL10 is a promising noninvasive biomarker for detection of renal
allograft rejection. The aim of this study was to investigate the clinical utility of renal allograft …
allograft rejection. The aim of this study was to investigate the clinical utility of renal allograft …
Antibody-mediated rejection of the liver allograft: An update and a clinico-pathological perspective
Antibody-mediated rejection after liver transplantation is an under-recognised cause of
allograft injury. While definitions of acute and chronic antibody-mediated rejection have …
allograft injury. While definitions of acute and chronic antibody-mediated rejection have …
[HTML][HTML] A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients
The last decade has seen an explosion of advanced assays for the diagnosis of infectious
diseases, yet evidence-based recommendations to inform their optimal use in the care of …
diseases, yet evidence-based recommendations to inform their optimal use in the care of …
[HTML][HTML] Substituting imputation of HLA antigens for high-resolution HLA typing: Evaluation of a multiethnic population and implications for clinical decision making in …
RM Engen, AM Jedraszko, MA Conciatori… - American Journal of …, 2021 - Elsevier
Molecular mismatch analysis for assessment of histocompatibility in transplantation requires
high-resolution HLA typing. Algorithms to “guesstimate” high-resolution from low-resolution …
high-resolution HLA typing. Algorithms to “guesstimate” high-resolution from low-resolution …
[HTML][HTML] Can we use eplets (or molecular) mismatch load analysis to improve organ allocation? The hope and the hype
In recent years, there have been calls for implementation of “epitope matching” in deceased-
donor organ allocation policies (later changed to “eplet matching”). Emerging data indeed …
donor organ allocation policies (later changed to “eplet matching”). Emerging data indeed …
[HTML][HTML] The evolving use of biomarkers in heart transplantation: consensus of an expert panel
In heart transplantation, the use of biomarkers to detect the risk of rejection has been
evolving. In this setting, it is becoming less clear as to what is the most reliable test or …
evolving. In this setting, it is becoming less clear as to what is the most reliable test or …